Onesource Specialty Pharma Limited has submitted to the Exchange, the financial results for the period ended September 30, 2025.
ONESOURCE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Onesource Specialty Pharma Limited has submitted its financial results for the quarter and half-year ended September 30, 2025 to the stock exchange. The filing itself is a compliance notice confirming submission and does not include the detailed financial numbers in this excerpt. Investors would need to refer to the full results document to see revenue, profit, margins, and other key line items. The submission is in line with the standard SEBI listing requirement for listed companies to file quarterly results within 45 days of quarter-end.
This is a routine regulatory filing and is not, by itself, a material event. Actual impact on the stock or shareholders will depend on the numbers in the detailed results, particularly any YoY revenue growth, profit trends, and margin movements compared to the September 2024 quarter.